Article citationsMore>>

Roupret, M., Pignot, G., Masson-Lecomte, A., Compérat, E., Audenet, F., Roumiguié, M., Houédé, N., Larré, S., Brunelle, S., Xylinas, E., Neuzillet, Y. and Méjean, A. (2018) French Recommendations of the AFU Cancer Committee-Update 2018-2020: Bladder Tumoursprogurol, Supplement 1, 28, R48.

has been cited by the following article:

• TITLE: Epidemiological and Clinical Aspects of Bladder Tumours at the Nianankoro Fomba Hospital in Segou in the Urology Department

  AUTHORS: Sory Ibrahim Kone, Honoré Jean Gabriel Berthe, Aly Douro Tembely, Zanafon Ouattara, Mamadou Lamine Diakite

  KEYWORDS: Bladder Tumour, Bladder Cancer, Epidemiological and Clinical Aspects

  JOURNAL NAME: Open Journal of Urology, Vol.12 No.5, May 30, 2022

  ABSTRACT: Objectives: To study the epidemiological, diagnostic and prognostic aspects of bladder tumours in Segou Hospital. Patients and Methods: We conducted a descriptive cross-sectional study of bladder tumours over the period from 1 April 2012 to 1 April 2017, in the urology department of the Nianankoro Fomba Hospital in Segou. The first three years were used for patient recruitment, and the last two years for follow-up of the patients in the series. Results: Over a period of three years, we collected 165 cases of bladder tumours hospitalised out of 1308 hospitalisations from 7007 consultations, i.e. 12.6% of hospitalisations and 2.3% of consultations. The sex ratio was 1.2 in favour of men. A history of treated bilharzia was reported in 78.8% of cases and untreated bilharzia in 9.1% of cases. Haematuria was the most common reason for consultation. The majority of our patients were at stage T4 and T3 at the time of diagnosis, i.e. 53.3% and 44.3% respectively. Most patients consulted within 13 to 24 months after the first sign, i.e. 44.8%. Conclusion: The prognosis is still clouded by the delay in management. All the patients diagnosed had a bladder tumour infiltrating the muscle.